Indonesia, April 27 -- Shanghai (ANTARA/PRNewswire)- Shanghai BioEngine Sci-tech Co., Ltd. announced the launch of UltraFeed, a next-generation fed-batch supplement designed to elevate CHO cell productivity in monoclonal antibody, bispecific, and recombinant protein manufacturing. Across diverse cell lines and molecule formats, UltraFeed delivers an average titer increase of 25%, with select programs achieving gains as high as 48% when compared to alternative feed media under identical basal conditions.

"UltraFeed addresses the critical challenges of volumetric productivity and process robustness that our partners encounter daily," said Dr. Li Fan, Senior Vice President of BioEngine's Antibody Business Unit. "We observe a mean titer incr...